Dibenzocyclooctadiene lignans from fructus schisandrae chinensis improve glucose uptake in vitro

Natural Product Communications

Volumn 5, Issue 2, 2010, Pages 231-234

  Zhang, Jing ^a   Shi, Lei Ling ^a   Zheng, Yi Nan ^a  

^a JILIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Dibenzocyclooctadiene lignans; Glucose uptake; Schisandra chinensis; Type 2 diabetes mellitus

Indexed keywords

ANGELOYLGOMISIN H; ANTIDIABETIC AGENT; DIBENZOCYCLOOCTADIENE LIGNAN; GLUCOSE; GOMISIN; LIGNAN DERIVATIVE; METHANOL; PLANT MEDICINAL PRODUCT; ROSIGLITAZONE; SCHISANDRA CHINENSIS EXTRACT; SCHISANDRIN A; SCHISANDRIN C; SCHISANDROL A; SCHIZANDRIN; SILICA GEL; UNCLASSIFIED DRUG; WUWEIZISU B; WUWEIZISU C; CYCLOOCTANE DERIVATIVE; LIGNAN;

ARTICLE; CELL STRAIN HEPG2; CHEMICAL STRUCTURE; COLUMN CHROMATOGRAPHY; DRUG ACTIVITY; DRUG ISOLATION; FRACTIONATION; FRUIT; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; SCHISANDRA CHINENSIS; CHEMISTRY; SCHISANDRACEAE;

SCHISANDRA CHINENSIS;

CYCLOOCTANES; FRUIT; LIGNANS; MOLECULAR STRUCTURE; SCHISANDRA;

EID: 77951924528     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1000500212     Document Type: Article

References (17)

1. Porte D Jr, Schwartz MW. (1996) Diabetes complications: why is glucose potentially toxic? Science, 272, 699-690.
2. Zhang B, Salituro G, Szalkowski D, Li ZH, Zhang Y, Royo I, Vilella D, Diez MT, Pelaez F, Ruby C, Kendall RL, Mao XZ, Griffin P, Calaycay J, Zierath JR, Heck JV, Smith RG, Moller DE. (1999) Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science, 284, 974-977.
3. Ball SW, Bailey JR, Stewart JM, Vogels CM, Westcott SA. (2002) A fluorescent compound for glucose uptake measurements in isolated rat cardiomyocytes. Canadian Journal of Physiology and Pharmacology, 80, 205-209. (Pubitemid 34264355)
4. Zou CH, Wang YJ, Shen ZF. (2005) 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. Journal of Biochemical and Biophysical Methods, 64, 207-215.
5. State Pharmacopoeia Commission of the People's Republic of China, (2005) Pharmacopoeia of the People's Republic of China, in Monographs, Part 1. Chinese materia medica, oil, fats, etc.: Fructus Schisandrae Chinensis, 1, 44-45.
6. Lau CH, Chan CM, Chan YW, Lau KM, Lau TW, Lam FC, Che CT, Leung PC, Fung KP, Ho YY, Lau CBS. (2008) In vitro antidiabetic activities of five medicinal herbs used in Chinese medicinal formulae. Phytotherapy Research, 22, 1384-1388.
7. Lu H, Liu G. (1992) Antioxidant activity of dibenzocyclooctene lignans isolated from Schisandraceae. Planta Medica, 58, 311-313.
8. Min H-Y, Park E-J, Hong J-Y, Kang Y-J, Kim S-J, Chung H-J, Woo E-R, Hung TM, Youn UJ, Kim YS, Kang SS, Bae K, Lee SK. (2008) Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells. Bioorganic & Medicinal Chemistry Letters, 18, 523-526.
9. Chen M, Kilgore N, Lee K-H, Chen D-F. (2006) Rubrisandrins A and B, lignans and related anti-HIV compounds from Schisandra rubriflora. Journal of Natural Products, 69, 1697-1701.
10. Ikeya Y, Taguchi H, Yosioka I, Kobayashi H. (1979) The constituents of Schizandra chinensis Baill. IV. The structure of two new lignans, pre-gomisin and gomisin J. Chemical & Pharmaceutical Bulletin, 27, 1583-1588.
11. Ikeya Y, Taguchi H, Yosioka I, Kobayashi H. (1979) The constituents of Schizandra chinensis Baill. I. Isolation and structure determination of five new lignans, gomisin A, B, C, F and G, and the absolute structure of schizandrin. Chemical & Pharmaceutical Bulletin, 27, 1383-1394.
12. Ikeya Y, Taguchi H, Yosioka I, Iitaka Y, Kobayashi H. (1979) The constituents of Schizandra chinensis Baill. II. The structure of a new lignan, gomisin D. Chemical & Pharmaceutical Bulletin, 27, 1395-1401. (Pubitemid 9237110)
13. Ikeya Y, Taguchi H, Yosioka I, Kobayashi H. (1979) The constituents of Schizandra chinensis Baill. III. The structure of four new lignans, gomisin H and its derivatives, angeloyl-, tigloyl- and benzoyl-gomisin H. Chemical &Pharmaceutical Bulletin, 27, 1576-1582.
14. Ikeya Y, Taguchi H, Yosioka I, Kobayashi H. (1979) The constituents of Schizandra chinensis Baill. V. The structures of four new lignans, gomisin N, gomisin O, epigomisin and gomisin E, and transformation gomisin N to deangeloylgomisin B. Chemical & Pharmaceutical Bulletin, 27, 2695-2709.
15. 13C nuclear magnetic resonance spectroscopy of dibenzocyclooctadiene lignans. Chemical & Pharmaceutical Bulletin, 28, 2414-2421.
16. Ikeya Y, Taguchi H, Yosioka I. (1982) The constituents of Schizandra chinensis Baill. XII. Isolation and structure of a new lignan, gomisin R, the absolute structure of wuweizisu C and isolation of schisantherin D. Chemical & Pharmaceutical Bulletin, 30, 3207-3211.
17. Yuan HB, Shen ZM, Yin JW, Xu LF. (2002) The hypoglycemic effect of alpha-glucosidase inhibitor separated from Schizandra chinensis [In Chinese]. Zhongguo Shang Hua Yao Wu Za Zhi, 23, 112-114.